Drug Type Unknown |
Synonyms- |
Target |
Mechanism PGES inhibitors(Prostaglandin E synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Gesynta Pharma ABStartup |
Active Organization Gesynta Pharma ABStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scleroderma, Systemic | Preclinical | - | Gesynta Pharma ABStartup | - |